Aptamer Group PLC, together with its subsidiaries, provides synthetic binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally. The company offers Optimer, a platform that enables the discovery and development of optimized DNA and RNA aptamers, which can bind to target molecules. Its platform is used in research reagent and analytical, bioprocessing, diagnostic, cosmetic and consumer health, and therapeutic applications. The company serves pharmaceutical, diagnostic, and bioprocessing companies. It has collaborations with Unilever, Neuro-Bio, the University of Glasgow, AstraZeneca, and Invizius. Aptamer Group PLC was founded in 2008 and is headquartered in York, the United Kingdom.
तुलना करने के लिए मीट्रिक्स | APTA | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंधAPTAपीअर्सक्षेत्र | |
|---|---|---|---|---|
पी/ई अनुपात | −10.9x | −6.5x | −0.6x | |
PEG अनुपात | −0.14 | −0.10 | 0.00 | |
क़ीमत/बुक | 19.1x | 5.1x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 22.0x | 6.4x | 3.4x | |
अपसाइड (विश्लेषक लक्ष्य) | - | 49.7% | 41.3% | |
उचित मूल्य अपसाइड | अनलॉक करें | −9.8% | 4.9% | अनलॉक करें |